More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...
Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...
Stock analysis is all about predictions – but as wits from Mark Twain to Yogi Berra have reminded us, predictions are hard, ...
As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of ...
Dexcom announced today that its G6 continuous glucose monitor (CGM) is being worn by astronauts as part of the Polaris Dawn ...
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
These once-sizable artificial intelligence (AI) holdings for Google parent Alphabet have been paired down big-time over the ...
Lost Money on DexCom, Inc.(DXCM)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
THE LAWSUIT: A class action securities lawsuit was filed against DexCom, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between January 8, ...
DexCom stock has fallen 41% this year, but investor sentiment for the maker of glucose monitoring devices could be changing.
The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback